Authors: Oefelein, MG Ricchuiti, V Conrad, W Seftel, A Bodner, D Goldman, H Resnick, M

Citation: Mg. Oefelein et al., Skeletal fracture associated with androgen suppression induced osteoporosis: The clinical incidence and risk factors for patients with prostate cancer, J UROL, 166(5), 2001, pp. 1724-1728

Authors: Oefelein, MG Feng, A Scolieri, MJ Ricchiutti, D Resnick, MI

Citation: Mg. Oefelein et al., Reassessment of the definition of castrate levels of testosterone: Implications for clinical decision making, UROLOGY, 56(6), 2000, pp. 1021-1024

Authors: Oefelein, MG Cornum, R

Citation: Mg. Oefelein et R. Cornum, Failure to achieve castrate levels of testosterone during luteinizing hormone releasing hormone agonist therapy: The case for monitoring serum testosterone and a treatment decision algorithm, J UROL, 164(3), 2000, pp. 726-729

Authors: Oefelein, MG

Citation: Mg. Oefelein, Serum testosterone-based luteinizing hormone-releasing hormone agonist redosing schedule for chronic androgen ablation: A phase I assessment, UROLOGY, 54(4), 1999, pp. 694-699

Authors: Oefelein, MG Ignatoff, JM Clemens, JQ Watkin, W Kaul, KL

Citation: Mg. Oefelein et al., Clinical and molecular followup after radical retropubic prostatectomy, J UROL, 162(2), 1999, pp. 307-310

Authors: Oefelein, MG

Citation: Mg. Oefelein, Disease progression following radical prostatectomy in men with Gleason score 7 tumor - J. I. Epstein, C. R. Pound, A. W. Partin and P. C. Walsh - J.Urol., 160 : 97-101, 1998, J UROL, 161(1), 1999, pp. 231-231